SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
INOVIO PHARMACEUTICALS
(AMEX:INO Last Sale: 11.23 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
AMEX: (INO : $11.23)
$1,638,627 million Market Cap at Market Close, May 4, 2020
Employs 33.
Biomedics SubIndustry up .00% / Health Industry up .00% Today

11199 Sorrento Valley Road Research Report Earnings Snapshot - Last 11/10/18
San Diego, CA 92121 Fact Sheet
Phone: (858) 597-6006 Financial Statements
Fax: (858) 597-0119 Peer Comparison
Annual Reports

Avtar Dhillon, Pres./CEO, Peter D. Kies, CFO
Formerly GENETRONICS BIOMEDICAL CORP and GENETRONICS BIOMEDICAL LTD (AMEX:GEB, TSE:GEB). Clinical applications are focused on oncology, dermatology, transdermal drug delivery, gene therapy and vascular therapy.
Historical Charts    Technical Analysis
No Historical Data available for INO

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common INO $11.23 $11.23 0 .0 $9.71 $11.34 26,922,790 $9.05 $11.34 145,915,100
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10111
Common Stock #############

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
04-APR-05 GEB Symbol Changed to INO
10-SEP-04 GEB Split 1 for 4
08-DEC-98 GBMDF Symbol Changed to GEB
12-OCT-94 GBMDF Stock Dividend 1.82142 for 1

A7
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2022 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex